Literature DB >> 11414647

High microvessel density in primitive neuroectodermal brain tumors of childhood.

M A Grotzer1, R Wiewrodt, A J Janss, H Zhao, A Cnaan, L N Sutton, L B Rorke, P C Phillips.   

Abstract

Microvessel density (MVD), a measure of tumor angiogenesis, has been shown to correlate significantly with overall and progression-free survival outcomes in various cancers including astrocytic brain tumors. To assess if the MVD is an independent prognostic factor in primitive neuroectodermal tumors (PNET) of the central nervous system, formalin-fixed paraffin-embedded tumor sections of 78 children with PNET were studied by CD34 immunohistochemistry to highlight endothelial cells. Microvessel density was determined in the most active area of neovascularization according to well-established methods. While it was shown that MVD showed considerable inter-tumor variability (median 75; range 20-345 microvessels per 0.7 mm2 field), no significant associations were found between MVD and metastasis or survival outcomes. We conclude that many PNETs are highly vascular CNS tumors, indicating potent angiogenic activity. Therefore, these tumors would be good candidates for antiangiogenic strategies. However, MVD determined in the most active area of neovascularization is not a predictor of metastatic potential or survival outcomes in childhood PNET.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414647     DOI: 10.1055/s-2001-13872

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  7 in total

1.  Angiogenesis and the growth potential of craniopharyngiomas.

Authors:  Sergio Vidal; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.

Authors:  Dolly Aguilera; Claire Mazewski; Jason Fangusaro; Tobey J MacDonald; Rene Y McNall-Knapp; Laura L Hayes; Sungjin Kim; Robert C Castellino
Journal:  Childs Nerv Syst       Date:  2013-01-08       Impact factor: 1.475

Review 3.  A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years.

Authors:  Alejandro Urberuaga; Aurora Navajas; Juan Burgos; José Ignacio Pijoán
Journal:  Childs Nerv Syst       Date:  2005-11-09       Impact factor: 1.475

Review 4.  Anti-angiogenic therapy in pediatric neuro-oncology.

Authors:  Mark W Kieran
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

Review 5.  Targeting Angiogenic Factors for the Treatment of Medulloblastoma.

Authors:  Zahraa Saker; Mahdi Rizk; Hisham F Bahmad; Sanaa M Nabha
Journal:  Curr Treat Options Oncol       Date:  2022-04-12

6.  Heterozygosity for Pten promotes tumorigenesis in a mouse model of medulloblastoma.

Authors:  Robert C Castellino; Benjamin G Barwick; Matthew Schniederjan; Meghan C Buss; Oren Becher; Dolores Hambardzumyan; Tobey J Macdonald; Daniel J Brat; Donald L Durden
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

7.  Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment.

Authors:  Yu Liang; Maximilian Diehn; Andrew W Bollen; Mark A Israel; Nalin Gupta
Journal:  J Neurooncol       Date:  2007-07-25       Impact factor: 4.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.